Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 36 resultados

HyFiDress: Excellence in the Research Area of Multifunctional Hybrid Hydrogel-Fibrous Constructs for Wound Dres... KLINIKUM DER UNIVERSITAET REGENSBURG participó en un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 HyFiDress aims at developing Excellence in the Research Area of Multifunctional Hybrid Hydrogel-Fibrous Constructs for Wound Dressings. This...
2024-04-19 - 2027-05-31 | Financiado

MICROBOTS: MICROBOTS – Unravel the power of MICRObial metaBOliTeS to prevent graft versus host disease and cure... KLINIKUM DER UNIVERSITAET REGENSBURG tramitó un HORIZON EUROPE: ERC-2023-COG Allogeneic stem cell transplantation (allo-SCT) is the most common cellular immunotherapy for hematologic malignancies, but beneficial outco...
2024-02-09 - 2029-05-31 | Financiado

exTra: Innovative Applications of Extracorporeal Photopheresis in Solid Organ Transplantation KLINIKUM DER UNIVERSITAET REGENSBURG tramitó un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 Organ transplantation remains the only definitive treatment for end-stage heart, lung, liver or kidney disease. Early transplant outcomes ar...
2023-09-01 - 2027-08-31 | Financiado

IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... KLINIKUM DER UNIVERSITAET REGENSBURG participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado

TTV GUIDE TX: PERSONALISATION OF IMMUNOSUPPRESSION BY MONITORING VIRAL LOAD POST KIDNEY TRANSPLANTATION A RANDOM... KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-SC1-BHC-2018-2020 Challenge: End stage renal disease (ESRD) causes high socioeconomic burden for citizens and the healthcare system in Europe. Kidney transpla...
2021-02-02 - 2026-04-30 | Financiado

ENVISION: Intelligent plug and play digital tool for real time surveillance of COVID 19 patients and smart dec... KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of in...
2020-10-13 - 2023-07-31 | Financiado

SciFiMed: Screening of inFlammation to enable personalized Medicine KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-FETOPEN-2018-2020 This transdisciplinary project will combine fundamental immunological research with novel nanomaterial-based biosensor development translate...
2020-05-26 - 2024-12-31 | Financiado

UNITI: Unification of treatments and Interventions for Tinnitus patients KLINIKUM DER UNIVERSITAET REGENSBURG tramitó un H2020: H2020-SC1-BHC-2018-2020 Tinnitus is the perception of a phantom sound and the patient’s reaction to it. Tinnitus remains a scientific and clinical enigma of iTinnit...
2019-11-24 - 2023-09-30 | Financiado

PAVE: A nanovaccine Approach for the treatment of Pancreatic Cancer KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-MSCA-ITN-2019 A Nanovaccine Approach For The Treatment of Pancreatic Cancer By Multicomponent Immuno-Modulation: Pancreatic ductal adenocarcinoma (PDAC) i...
2019-09-12 - 2024-03-31 | Financiado

INsTRuCT: INnovative Training in Myeloid Regulatory Cell Therapy KLINIKUM DER UNIVERSITAET REGENSBURG tramitó un H2020: H2020-MSCA-ITN-2019 Cell therapy is an active area of immunological research and represents a highly innovative and rapidly expanding sector of pharmaceutical i...
2019-08-19 - 2024-06-30 | Financiado

MEFISTO: MEFISTO Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-NMBP-TR-IND-2018-2020 MEFISTO will develop two novel solutions to treat meniscus loss as a strategy for preventing the onset of an epidemic of post-meniscectomy k...
2019-03-05 - 2024-11-30 | Financiado

Achilles: Overcoming specific weaknesses in tendon biology to design advanced regenerative therapies KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-WIDESPREAD-2016-2017 The main goal of Achilles is to significantly strengthen the science and technology capacity of UMinho in biophysics, cell/molecular biology...
2018-06-27 - 2022-06-30 | Financiado

SILICOFCM: In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial ca... KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-SC1-2016-2017 According to the 2014 European Society of Cardiology Guidelines, cardiomyopathies are defined as structural and functional abnormalities of...
2018-05-08 - 2022-02-28 | Financiado

ESIT: European School for Interdisciplinary Tinnitus Research KLINIKUM DER UNIVERSITAET REGENSBURG tramitó un H2020: H2020-MSCA-ITN-2016 The European School for interdisciplinary tinnitus research (ESIT) provides an opportunity for young researchers to work on leading-edge res...
2017-04-05 - 2021-06-30 | Financiado

BEAt-DKD: Biomarker Enterprise to Attack DKD Sofia ref. 115974 KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-JTI-IMI2-2015-05-two-stage Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached e...
2016-12-20 - 2023-08-31 | Financiado

EN_ACTI2NG: European Network on Anti Cancer Immuno Therapy Improvement by modification of CAR and TCR Interactio... KLINIKUM DER UNIVERSITAET REGENSBURG participó en un H2020: H2020-MSCA-ITN-2016 The EN-ACTI2NG program (European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale...
2016-08-31 - 2021-04-30 | Financiado